Applying for a grant

... Research & Impact
Applying for a grant

ACRF Research Grants

ACRF awards capital grants (between $1.5 Million to $5 Million) for technology, equipment and infrastructure for cancer research at Australian medical research institutes, hospitals and universities.

Grant applications are open to research into all types of cancer with a research focus on detection, prevention and/or treatment.

Since 1984, ACRF has awarded $204 million to 90 research grants in 44 Australian cancer research institutes.

ACRF promotes collaboration amongst researchers and clinicians and encourages novel and innovative cancer research projects. All applications are competitively reviewed by the ACRF Medical Research Advisory Committee (MRAC) who recommend the best projects to the ACRF Board of Trustees for funding.

2024 Annual Research Grants

The 2024 ACRF Grant Round has now closed. The successful applicants will be officially announced in November 2024. Please use the links below as reference documents for eligibility for future applications (new Guidelines and Format documents will be available in February 2025).

2024 ACRF Annual Grants Guidelines and 2024 Annual Grants Format of Grant Application.

2024 Major Grant

The 2024 ACRF Major Grant Round has now closed.

The successful applicants will be officially announced in November 2024.

Find out more about ACRF grants process

ACRF grants have led to some ground-breaking discoveries

Development of a new HPV Cervical Cancer Vaccine

ACRF gave initial seed funding to Professor Ian Frazer’s research into the cervical cancer (HPV) vaccine. Over 150 million doses of the vaccine have been delivered worldwide to date.

Major study which uncovered new breast cancer genes

ACRF has given three grants, totalling AUD 8.4 million to QIMR Berghofer Medical Research Institute which led to a team of researchers at this Institute discovering at least 12 new genes that influence the risk of developing breast cancer.

A new blood test that detects early stages of cancer

ACRF provided $5.5 million in funding to The Walter and Eliza Hall Institute where researchers developed a blood test that can detect the presence of eight common cancers. The test has been shown to reliably detect early stage and curable cancers.